載入...
Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance
Urokinase plasminogen activator receptor (uPAR), a member of the lymphocyte antigen 6 protein superfamily, is overexpressed in different types of cancers and plays an important role in tumorigenesis and development. In this study, we successfully targeted uPAR by CRISPR/Cas9 system in two human canc...
Na minha lista:
| 發表在: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6400983/ https://ncbi.nlm.nih.gov/pubmed/30873379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00080 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|